New Endocrine Society and European Endocrine Society guidelines provide a much-needed update Making its debut at ENDO 2025, “Diabetes and Pregnancy: An Endocrine Society and European Society of Endocrinology Joint Clinical Practice Guideline” has been long anticipated. For the first time, clinicians will have a definitive guide on treating these patients that now includes the...
The Endocrine Society is pleased to welcome Carol Lange, PhD, who takes office during ENDO 2025 in San Francisco. Lange succeeds John Newell-Price, MD, PhD, FRCP. Lange is a professor of medicine and molecular pharmacology and therapeutics, and holds the Tickle Family Land Grant Endowed Chair of Breast Cancer Research, and is the associate director...Tightrope: Obesity Management in Women During Reproductive Years
As part of the ENDO 2025 session, “Obesity Management Across the Lifespan: Special Considerations,” Lisa Morselli, MD, PhD, talks about the unique challenges in obesity management in women during their reproductive years. On Tuesday, July 15, ENDO 2025 here in San Francisco will feature a session titled, “Obesity Management Across the Lifespan: Special Considerations.” As... An Endocrine News roundup of the week’s pharmaceutical news, breakthroughs, and general information. * Recordati Rare Diseases Announced New Data in Cushing’s Syndrome, Cushing’s Disease, and Post-Bariatric Hypoglycaemia at ENDO 2025 In April 2025, the FDA approved an expanded indication for ISTURISA® (osilodrostat) for the treatment of endogenous hypercortisolemia in adults with Cushing’s syndrome Recordati Rare...
AI-Powered Mobile Retina Tracker Screens for Diabetic Eye Disease with 99% Accuracy
A novel AI-powered retina tracker can analyze retinal images with near-perfect accuracy in under one second, according to a study being presented Monday at ENDO 2025, the Endocrine Society’s annual meeting in San Francisco, Calif. The researchers say the findings offer hope for sight-saving screenings for diabetic retinopathy and other eye diseases that are fast, affordable,...
Anti-Obesity Medications Can Normalize Testosterone Levels in Men
Anti-obesity medications can significantly raise testosterone levels and improve health outcomes for men with obesity or type 2 diabetes, according to a new study being presented Monday at ENDO 2025, the Endocrine Society’s annual meeting in San Francisco, Calif. Testosterone not only plays a critical role in the body when it comes to male sexual...
Women who work night shifts may have an increased risk for irregular periods and hormonal imbalances, according to a study being presented Monday at ENDO 2025, the Endocrine Society’s annual meeting in San Francisco, Calif. “Shiftwork-like light exposure disrupts the body’s internal timing, causing a split response where some females have disrupted reproductive cycles and...
Endocrine Society Guideline Calls for Increased Screening for Common High BP Culprit
Many primary aldosteronism cases remain undiagnosed and untreated Endocrine Society experts encouraged more widespread screening for a common hormonal cause of high blood pressure known as primary aldosteronism in a new Clinical Practice Guideline released today. “Primary Aldosteronism: An Endocrine Society Clinical Practice Guideline” was published online and is being presented at ENDO 2025, the...
